Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
nScrypt is a leading manufacturer of high-precision micro-dispensing and 3D manufacturing systems, with a specialized focus on the life sciences through its bioprinting technology. The company's "Factory in a Tool" (FiT) platform integrates multiple functions—such as dispensing, milling, and picking-and-placing—into a single automated system. In the healthcare sector, nScrypt provides advanced bioprinting solutions capable of precisely depositing cells, extracellular matrices, and biomaterials for tissue engineering and regenerative medicine. Their technology is utilized by research institutions and commercial entities to develop complex biological structures, including skin, bone, and vascularized tissues. Notably, nScrypt has collaborated with NASA and the military to advance bioprinting in extreme environments, including the International Space Station.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on nScrypt.